1A2D image
Deposition Date 1997-12-29
Release Date 1998-07-01
Last Version Date 2023-08-02
Entry Detail
PDB ID:
1A2D
Title:
PYRIDOXAMINE MODIFIED MURINE ADIPOCYTE LIPID BINDING PROTEIN
Biological Source:
Source Organism:
Mus musculus (Taxon ID: 10090)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.40 Å
R-Value Free:
0.27
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:ADIPOCYTE LIPID BINDING PROTEIN
Gene (Uniprot):Fabp4
Chain IDs:A, B
Chain Length:131
Number of Molecules:2
Biological Source:Mus musculus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
PYX A CYS S-[S-THIOPYRIDOXAMINYL]CYSTEINE
Ligand Molecules
Primary Citation
Structural characterization of two synthetic catalysts based on adipocyte lipid-binding protein.
Protein Eng. 11 253 261 (1998)
PMID: 9680187 DOI: 10.1093/protein/11.4.253

Abstact

Adipocyte lipid-binding protein (ALBP) is a small (14.5 kDa) 10-stranded beta-barrel protein found in mammalian fat cells. The crystal structures of various holo-forms of ALBP have been solved and show the fatty acid ligand bound in a large (approximately 400 A3) cavity isolated from bulk solvent. Examination of the cavity suggests that it would be a good site for the creation of an artificial catalyst, as numerous well defined crystal structures of ALBP are available and past studies have shown the conformation to be reasonably tolerant to modification and mutagenesis. Previous work has shown ALBP to be a good protein scaffold for exploring enantio- and stereoselective reactions; two constructs, ALBP attached to either a pyridoxamine or a phenanthroline group at C117, have been chemically characterized. Both modified proteins have been crystallized and their structures solved and refined. The X-ray models have been used to examine the origin of the chiral selectivity seen in the products. It is apparent that these covalent adducts reduce the internal cavity volume, sterically limiting substrate interactions with the reactive groups, as well as solvent access to potential intermediates in the reaction pathway.

Legend

Protein

Chemical

Disease

Primary Citation of related structures